# A Novel Combination Oral Agent to Treat Acne Vulgaris

> **NCT01301586** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Nexgen Dermatologics, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- ACNE VULGARIS

## Interventions

- **DRUG:** Doxycycline and S-equol
- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT01301586
- **Lead sponsor:** Nexgen Dermatologics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301586, "A Novel Combination Oral Agent to Treat Acne Vulgaris". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01301586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*